A Retrospective Data Audit of Outcome of Moderate and Severe Covid-19 Patients Who Had Received MP and Dex: A Single Center Study
GC use is beneficial in mitigating exacerbations in moderate patients and in patients with moderate COVID-19. In severe patients, MP reduces the number of hospitalization days compared with DEX and may be a superior choice.
Authors
- Xinrui Tian
- Liting Feng (ORCID: https://orcid.org/0009-0009-8390-8092)
- Zhen Ma (ORCID: https://orcid.org/0000-0001-8650-3714)
- Xianglin L. Du (ORCID: https://orcid.org/0000-0003-0119-5252)
- Qian Wu (ORCID: https://orcid.org/0000-0001-9790-074X)
- Rujie Huo (ORCID: https://orcid.org/0000-0001-5232-5710)
- Lulu Zhang (ORCID: https://orcid.org/0000-0003-1717-0199)
- Peiqi Li
- Erjing Cheng (ORCID: https://orcid.org/0009-0006-3547-1891)
- Yupeng Li
- Xinkai Ma
- Dai Liu
- Yanqing Xing (ORCID: https://orcid.org/0000-0002-4000-5784)
- Fei Hu (ORCID: https://orcid.org/0000-0001-7071-1375)
- Yanting Dong (ORCID: https://orcid.org/0000-0003-0297-1620)
- Xinli Tian (ORCID: https://orcid.org/0009-0004-9516-1153)
- Chuanchuan Dong
Institutions
- Shanxi Medical University (CN)
- Chinese PLA General Hospital (CN)
- Second Hospital of Shanxi Medical University (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/idr.s418788
- Citations
- 1
- Primary Topic
- Dermatological and COVID-19 studies
- Type
- article
- Field-Weighted Citation Impact
- 0.53